BrightPath Biotherapeutics Co., Ltd. Stock
Equities
4594
JP3274140007
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
58 JPY | 0.00% | -3.33% | -33.33% |
Sales 2017 | 529M 3.42M | Sales 2018 | 354M 2.29M | Capitalization | 33.68B 218M |
---|---|---|---|---|---|
Net income 2017 | -1.11B -7.19M | Net income 2018 | -1.58B -10.19M | EV / Sales 2017 | 34.8 x |
Net cash position 2017 | 4.95B 31.98M | Net cash position 2018 | 6.53B 42.18M | EV / Sales 2018 | 76.7 x |
P/E ratio 2017 |
-19.2
x | P/E ratio 2018 |
-19.5
x | Employees | 42 |
Yield 2017 * |
-
| Yield 2018 |
-
| Free-Float | 95.52% |
1 week | -3.33% | ||
Current month | -13.43% | ||
1 month | -12.12% | ||
3 months | -32.56% | ||
6 months | -50.00% | ||
Current year | -33.33% |
Managers | Title | Age | Since |
---|---|---|---|
Kenichi Nagai
CEO | Chief Executive Officer | 53 | 08-12-31 |
Director/Board Member | 55 | 16-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 77 | 15-05-31 | |
Akira Yamada
BRD | Director/Board Member | 67 | 03-04-30 |
Kenichi Nagai
CEO | Chief Executive Officer | 53 | 08-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 58 | 0.00% | 248 700 |
24-04-22 | 58 | +3.57% | 273,700 |
24-04-19 | 56 | -3.45% | 498,600 |
24-04-18 | 58 | +1.75% | 229,900 |
24-04-17 | 57 | 0.00% | 459,700 |
Delayed Quote Japan Exchange, April 23, 2024 at 02:00 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-33.33% | 25.54M | |
+2.10% | 42.11B | |
+49.05% | 40.08B | |
+7.89% | 40B | |
-11.32% | 26.87B | |
+6.44% | 24.58B | |
-21.97% | 18.44B | |
+1.54% | 11.94B | |
+28.93% | 11.66B | |
+8.14% | 11.01B |
- Stock Market
- Equities
- 4594 Stock